Marc Beer has created an impressive career reputation over the years. One attribute to his success is the proficiency in which he handles challenges and his flexibility in finding solutions. His level of education and natural ability have shaped his career. Marc began in the sales and marketing sector for a pharmaceutical company, Genzyme (NASDAQ: GENZ) where he was later appointed as the Vice President of Global Marketing.
While at the company, he pushed a product line that would help approximately 350 million individuals suffering from various rare ailments. Given his position in the company, he was able to sell the product line into the market. His work at Genzyme brought on a desire to do more for those who were underprivileged. He wanted to provide solutions for what was lacking in the pharmaceutical industry.
With his years of experience in the field, he felt he had what it takes to start his venture. The need to help the underprivileged was the motivation behind his first company, ViaCell, in 2000. ViaCell was a biotech firm that had over 300 workers and had an Initial Public Offer on NASDAQ as VIAC. The firm primarily focused on treating numerous diseases through the conservation of the blood stem cells of the umbilical cord.
It was seven years later that he decided to sell ViaCell to PerkinElmer who bought it at $300 million. By the time, everything seemed to fall into place, both his career and the corporate world. Sadly, this was when everything began falling to pieces. As soon as he sold ViaCell, he lost his wife at 42 years to a pulmonary embolism.
Marc found comfort in bringing up his three children as a stay at home, dad. Two years down the line, his 14-year old daughter challenged him to do more with his life and continue with the entrepreneur’s pursue. He saw this as a wake-up call and once again founded another successful company, Renovia. At Renovia, Marc works as the CEO with the help of another founder Dr. Ray Iglesias.
The idea behind founding the company came from Dr Ray Iglesias, who has spent the last 35 years as a surgeon operating on women with pelvic floor conditions. Dr. Iglesias had tried to devise ways to assist these women in doing away with the surgery for close to ten years. When he gave Marc a call and told him of his ideas, Marc was impressed and eager to work on the project. Renovia was founded in 2016 under a partnership of Marc Beer, Dr. Iglesias, and Yolanda Lorié. Learn more: https://www.prnewswire.com/news-releases/lumenxt-names-marc-beer-chairman-of-the-board-300822547.html
Before joining Genzyme, Marc Beer worked as a marketer at Abbott Laboratories (NYSE: ABT) in the pharmaceutical department. He holds a Bachelor of Science in Business from Miami University. He has been a part of the Mass Life Science Board of the Commonwealth of Massachusetts and the Biotechnology Industry Organization (BIO) Emerging Companies Section Governing Board. Marc Beer also served as President of the board at Good Start Genetics, Inc, which was later incorporated by InVitae (NASDAQ: NVTA).